nalmefene associated_with fatigue
Evidence from:
primary |
all sources
Evidence (1 sources)
The adverse events reported most commonly with nalmefene (vs. placebo) were fatigue (8.3% vs. 4.6%)
confidence: 0.96
The adverse events reported most commonly with nalmefene (vs. placebo) were fatigue (8.3% vs. 4.6%)